Ailene Medalla
Family Medicine · Chesapeake, VANPI 1508252461
Payments from drug & device makers
Across 166 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$551
- Novo Nordisk$437
- Pfizer$212
- Amarin Pharma, Inc.$114
- GSK$112
- Merck$111
- plus $998 from 27 others
What the payments were for
- Food & beverage$2,534100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $551 |
| Novo Nordisk | 29 | $437 |
| Pfizer | 16 | $212 |
| Amarin Pharma, Inc. | 7 | $114 |
| GSK | 6 | $112 |
| Merck | 8 | $111 |
| Lilly USA, LLC | 8 | $110 |
| Abbott | 6 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $100 |
| Boehringer Ingelheim | 5 | $81 |
| Tris Pharma Inc | 4 | $71 |
| Sanofi Pasteur Inc. | 2 | $48 |
| Medtronic | 1 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $38 |
| Genentech USA, Inc. | 3 | $38 |
| Amgen | 2 | $33 |
| AstraZeneca | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Dermira, Inc. | 1 | $20 |
| Novartis | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Scynexis, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$2,534 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 87 | $730 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 12 | $529 |
| Losartan Potassium | 49 | $477 |
| Ezetimibe | 15 | $456 |
| Levothyroxine Sodium | 32 | $398 |
| Amlodipine Besylate | 47 | $314 |
| Metoprolol Succinate | 19 | $308 |
| Lisinopril | 32 | $303 |
| Famotidine | 24 | $299 |
| Pravastatin Sodium | 22 | $291 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 26 | $286 |
| Montelukast Sodium | 30 | $266 |
| Metformin Hcl ErMetformin Hcl | 21 | $224 |
| Hydrochlorothiazide | 20 | $190 |
| Potassium Chloride | 13 | $178 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chesapeake
- Samir AbdelshaheedChesapeake$642K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.